Found: 4
Select item for more details and to access through your institution.
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
- Published in:
- Cancer Imaging, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s40644-022-00513-y
- By:
- Publication type:
- Article
Complementarity-determining region clustering may cause CAR-T cell dysfunction.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40303-z
- By:
- Publication type:
- Article
Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks.
- Published in:
- Nanomaterials (2079-4991), 2020, v. 10, n. 4, p. 783, doi. 10.3390/nano10040783
- By:
- Publication type:
- Article